The FDA recently announced that semaglutide and tirzepatide—the active ingredients in popular weight loss and diabetes drugs like Ozempic, Wegovy, and Zepbound—are no longer in shortage. Because of this, compounding pharmacies will soon have to stop making and selling these medications. However, many pharmacies disagree. A group representing compounding pharmacies has filed a lawsuit against […]

The post FDA Ends Shortage of Semaglutide and Tirzepatide – What It Means for You appeared first on Me Wellness & Medspa.